Heparan sulphate binding to cells of the gastric pathogen
Introduction
Heparan sulphate and other sulphated glycosaminoglycans (GAGS) are exposed on eukaryotic cell surfaces and extracellular matrix (ECM) [ 13. Several pathogenic micro-organisms and viruses -such as Bordetella pertussis, Streptococcus mutans, Leishmania donovani, Tqpanosoma cruzi, Plasmodium circumsporozoites, Chlamydia trachomatis, human immunodeficiency virus, herpes virus and cytomegalovirus -interact with host cells by binding to sulphated GAG-molecules on cell surfaces and ECM [2-151. Heparin and heparan sulphate binding to Staphylococcus aureus and Streptococci of groups A, C, and G with moderate affinity (& = 10-5-10-7 M) [16] and to Helicobacter pylori with high affinity (& = 10-9-10-'0 M) [17] , equivalent to the high affinity reported for heparin binding to C. trachomatis [ 181, has been reported previously.
Moreover, binding of '251-labelled heparan sulphate to H. pylori was shown to be pH and salt dependent [17] . A recent report demonstrated that H. pylori
Materials and methods

Chemicals
Bovine lung heparan sulphate (HS-3, medium content of sulphate groups) was a generous gift from L.-A. Fransson (Department of Medical Chemistry, Lund University).
Heparin (porcine intestinal mucosa, mol. wt 6000-8000) was purchased from Fluka (Heidelberg, Germany); dextran sulphate (mol. wt 5000 = DS 5000, mol. wt 8000 = DS 8000 and mol. wt 500000 = DS 500000), chondroitin sulphate A, B and C, (Ch.SO4 A, Ch.SO4 B and Ch.SO4 C, respectively), fucoidan, carrageenan4 from Gigantia aciculaire and G. pistillata, hyaluronic acid from bovine trachea, pentosan polysulphate (PP-SoLC), N-acetylneuraminic acid type VIII from sheep submaxillary glands, 2-desoxyglucosamine-2-sulphate, N-acetylglucosamine-6-sulphate, and N-acetylgalactosamine-6-sulphate were purchased from Sigma; bovine submaxillary gland mucin was purchased from Worthington (Freehold, NJ, USA), and dextran (mol. wt 250000) from Pharmacia (Uppsala, Sweden). Dextran sulphate mol. wt 5000 (DS 5000), dextran sulphate mol. wt 500000 (DS 500,000), and long-arm biotin hydrazide and aminocarbazole were purchased from Sigma; basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) were purchased from Boehringer Mannheim (Mannheim, Germany). Blocking (SAT-1) and washing buffer were obtained from M. Rucheton, Orston Laboratoire, Montpelier, France. All chemicals were of analytical grade and Millipore grade de-ionised water was used in all experiments.
Strains and culture conditions
Seven strains of Helicobacter pylori (25, 1139, 17874, 17875, 915 , 66 and 33) from the University of Lund collection were studied.
All strains were grown in micro-aerophilic conditions at 37°C for 3 days on GAB-CAMP agar with defibrinated horse blood 5% v/v [20] . The bacteria were harvested in 0.01 M sodium phosphate buffer, pH 7.2, containing 0.15 M NaCl (PBS), washed once with PBS and suspended in PBS, pH 7.2 or 4.5, to a final density of 10" cfu/ml. Cells were pretreated with water, 1 M LiCl and 0.2 M acid glycine, pH 2.2, at room temperature for 1 h. Cells were harvested by centrifugation at 3000 g for 15 rnin and suspended in PBS, pH 7.2 or 4.5, to a final cell density of 10" cfdml.
Binding assay
Heparan sulphate (HS-3) was derivatised at the aamino group of the residual serine with p-hydroxyphenyl propionate and labelled with 1251 as described by Fransson et al. [21] . The binding of 1251-labelled HS-3 to H. pylori was quantified as described previously [ 161. Briefly, samples of 1251-labelled HS-3 (c. 25 000 cpm) were added to cell suspensions ( lo9 cfu in 200 pl) in a selected binding buffer (i.e., buffers with different pH value or different salt content) supplemented with bovine serum albumin 0.1% and 0.15 M NaCl and kept at 20°C for 1 h. To each cell suspension, 2 ml of a binding buffer (PBS, pH 7.2 or 4.5, presence or absence of NaC1) containing Tween 20 0.05% was added. The tubes were centrifuged (2000 g 10 min), supernates were aspirated and bound radioactivity was determined in a gamma-counter (CliniGamma, LKB-Pharmacia, Uppsala, Sweden). All experiments were performed in duplicate and the mean value of the bound HS-3 was calculated by dividing bound radioactivity by total added radioactivity and correcting for any background radioactivity.
Binding inhibition assay
H. pylori cells (lo9 cfu) in 100 pl of binding buffer were mixed with 100 pl of buffer solution containing 250-2.5 pg putative inhibitor and kept at 20°C for 1 h. 1251-labelled HS-3 was added to each tube and incubated at 20°C for 1 h. These solutions were centrifuged after washing with incubation buffer and the residual cell-bound radioactivity in the pellets was determined in the gamma counter.
Preparation of outer membranes
H. pylori outer membranes were prepared as described by Doig and Trust [22] . Briefly, cells were washed with PBS and suspended in PBS containing 1 mM phenylmethylsulphonyl fluoride (PMSF) as protease inhibitor. Cells were disrupted by sonication (10 x 30 s at 30 W on ice). Whole cells and cell debris were removed by centrifugation (5000 g, 15 min). Membranes (as cell envelopes) were collected by centrifugation (40 000 g, 1 h) at 4°C. Pellets were collected and treated with sodium lauroylsarcosine 2% for 30 min at room temperature to remove inner membranes. An outermembrane (OM) preparation was collected by centrifugation (40000 g, 1 h, 4°C) and suspended in water for SDS-PAGE and Western blotting.
SDS-PA GE and Western blotting
H. pylori OM proteins were separated and analysed by SDS-PAGE (12% gel or gradient gel 5-20%) with the buffer system of Laemmli [23] . Outer membranes, treated with lauroylsarcosine 2%, were washed once with PBS and dissolved in SDS-PAGE sample buffer. After SDS-PAGE, proteins were transferred to a 0.45-pm nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany) or PVDF membrane (Millipore, Bedford, USA) by a semi-dry blotting technique (Ancos, Vig, Denmark). Membranes were blocked with SAT 1 for 15 rnin at room temperature, cut into 5-10-mm strips and used in a biotin-heparin assay.
Biotinylation of heparin
Heparin (2 mg) was dissolved in 500 pl of 0.1 M sodium acetate buffer, pH 5.5, and 5 x 20-pl volumes of periodate solution (20 mg in 850 pl of water) were added to the heparin solution at 2-min intervals. After incubation for an additional 20 rnin in the dark, excess periodate was neutralised by adding 10 pl of sodium metabisulphite solution (19 mg in 100 pl of water) and 20 pl of long-arm biotin-hydrazide (1 mg/ml, dissolved in dimethylsulphoxide, DMSO) was added to the heparin solution. After overnight incubation with shaking, 100 pl of ethanolamine was added and incubated for 1 h. The non-reacted biotin-hydrazide was separated on a Fast Desalt column (Pharmacia, Sweden) equilibrated with water and fractions eluting at the void volume were lyophilised. Biotin-heparin at the concentration 1 mg/ml was dissolved in water and used as a stock solution for the biotin-heparin assay.
Biotin -h eparin assay
The strips of nitrocellulose were incubated in 7 ml of binding buffer (for pH study buffers with different pH; or different concentrations of salt, in the presence or 
Binding assay with biotin-labelled growth factors
Binding assays with biotin-labelled bFGF and EGF were performed in PBS at pH 5.5 and 6.5 in the presence or absence of heparin, respectively. The strips were incubated with 50 ng of growth factors. All other conditions were the same as in the biotin-heparin assay.
.-
Results
Binding of HS-3 to H. pylori cells of seven of the strains at neutral pH was very low. Only cells of strains 25 and 1139 bound HS-3 to a level above the background at neutral pH. However, HS-3 binding increased dramatically at pH 4.5 up to 60-70% of the total HS-3 for some strains (Fig. 1) . concentrations of 250 pglml and an increased salt concentration. To differentiate between the ability of compounds to give complete inhibition of binding, the effect of dilutions of various inhibitors was studied (Fig. 3) .
More detailed analysis of the binding of '251-labelled HS-3, heparin and DS 5000 were performed for strains 25 and 17874 (Fig. 4) . From these data the IC50 values (i.e., concentration of inhibitor giving OM proteins were separated on SDS-PAGE and analysed by Western blotting with the biotin-heparin assay; three-to-four bands in the range 15-60 kDa were separated, confirming the location of HepBP-s on the cell surface (Fig. 5) . Also, biotinylation of cell-surface proteins before separation of OM revealed the same bands as in the biotin-heparin assay (data not shown). Finally, an indirect immunofluorescence assay with a rabbit antiserum raised against a 57-kDa polypeptide in the 55-60 kDa region confirmed the location of this protein on the cell surface (data not shown).
When the pH was increased from 4.5 to 7.5, the binding of labelled heparin decreased and, finally, only the 55-60-kDa polypeptide gave a, positive reaction at pH 6.5 and 7.2 in PBS (Fig. 5: lanes 1, 3, 5, 7 and 10). The same polypeptide reacted with biotin-bFGF at pH 5.5 in the presence of heparin, but not in its absence (Fig. 5: lanes 14 and 12) . The binding assay with biotin-EGF at pH 6.5 did not reveal any reactive bands with or without heparin (data not shown).
Discussion
A number of studies have shown that heparin, heparan sulphate (HS) and other glycosaminoglycans (GAGS) are involved in the binding of some specific viruses and pathogenic microbes to eukaryotic cells [2-131.
HS binding to H. pylori cells at a pH 4-6 seems to be a common feature (Fig. 1) . In the upper gastric mucin layer, the pH value is c. 2-3, which increases closer to the epithelial cell surface (about pH 7). 1 2 3 4 5 6 7 8 9 x H l l 2 l 3 1 4 Fig. 5 . Biotin-heparin assay with H. pylori strain 25 outer-membrane proteins separated on SDS-PAGE, transferred to nitrocellulose and probed with biotin-labelled heparin at pH 4.5-7.5. Lane 1, 50mM KH2P04, pH 4.5; 3, 50 mM KHzP04, pH 5.5; 5 , 50 mM KHlP04, pH 6.5; 7, 50 mM KH2P04, pH 7.5; 10, PBS, pH 7.2; 12, 50 mM KH2P04, pH 5.5, + bFGF; 13, 50 mM'KH2P04, pH 6.5, + bFGF; 14, 50 mM KH2P04, pH 5.5, + heparin + bFGF; 2, 4, 6, 8, 9 , 11, control with streptavidin-HRP. (Fig. 3) .
HS, dermatan sulphate and chondroitin sulphate are glycosaminoglycans on cell surfaces and in the extracellular matrix [24] . The binding of '251-labelled HS-3 was strong at physiological salt concentrations (at pH 4.5) and was almost abolished if 0.5 M NaCl was added, indicating that mainly ionic interactions are involved. Structurally different polysaccharides gave strong inhibition of '251-labelled HS-3 binding to H. pylori cells, indicating that the oligosaccharide structures are not so important as the density of sulphate groups on these polymers. Interestingly, nonsulphated hyaluronic acid with a similar structure to heparin, HS and chondroitin 4-and 6-sulphates did not inhibit HS binding to cells of the seven H. pylori strains, whereas a structurally different heparinoid (pentosan polysulphate) gave a strong inhibition (Fig. 3) . On the contrary, sulphated monosaccharide had low inhibitory activity (data not shown).
Monophasic inhibition curves for heparin are typical for non-selective competitors and the IC50 value demonstrates moderate binding affinity of heparin to the HS cell-surface proteins of H. pylori.
A number of tissue-invasive bacterial pathogens bind to specific cell-surface glycoproteins and glycolipids on epithelial cells. Following epithelial damage, some of these pathogens may also bind to subepithelial structures such as various extracellular matrix (ECM) molecules to promote tissue colonisation and survival.
Previously studies have shown that H. pylori specifically interacts with two major basal membrane ECM molecules, collagen type IV and laminin [25, 26] . The following hypothesis attempts to define the possible role of HS binding to specific surface molecules of H. pylori in the gastric epithelium and in subepithelial extracellular matrix. It seems likely that H. pylori may first interact with sialoglycoconjugates and Lewis blood group structures in the lower gastric mucin layer and on epithelial cell surfaces [27] . Binding to cell-surface GAG molecules may trigger cell interactions, as proposed for other GAG-binding pathogens such as trypanosomes and chlamydiae [28, 29] . However, GAG binding to H. pylori -together with binding to ECM molecules, including fibronectin, vitronectin, type IV collagen and laminin -may allow it to become coated efficiently with host molecules capable of preventing attack by professional phagocytes and a strong immune response. This may in part explain why H. pylori is a 'slow pathogen' [30, 31] , allowing survival for decades in the gastric mucosa of patients with chronic type B gastritis.
In conclusion, H. pylori cells interact strongly with HS at a low pH value (4.5) and more than a surface protein are involved in this interaction. According to the biotin-heparin assay, only the protein in the 55-60 kDa region interacts with heparin at a neutral pH (6-7). Although the H. pylori cell-surface proteins do not bind bFGF and EGF at pH 5-7, this may occur when the 'bridge' is provided by the heparin molecule.
